Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial (2017)

Peer-Reviewed Study · Nangia J, Wang T, Osborne C, Niravath P, Otte K, Papish S, Holmes F, Abraham J, Lacouture M, Courtright J, Paxman R, Rude M, Hilsenbeck S, Osborne CK, Rimawi M · February 14, 2017

Nangia J et al., 2017-02-14: The SCALP randomised trial of scalp cooling in 182 women with breast cancer: 50.5% of cooled women preserved hair versus 0% of controls, i.e. about half, which is the 'only partly effective' reading.

Successful hair preservation was found in 48 of 95 women with cooling (50.5%; 95% CI, 40.7%-60.4%) compared with 0 of 47 women in the control group (0%; 95% CI, 0%-7.6%) (success rate difference, 50.5%; 95% CI, 40.5%-60.6%).

Abstract, Results

Nangia J et al., 2017-02-14: The SCALP randomised trial of scalp cooling in 182 women with breast cancer: 50.5% of cooled women preserved hair versus 0% of controls, i.e. about half, which is the 'only partly effective' reading. Study type: randomized trial.